Sensing the probable side effects of cholesterol drug, Sanofi, the Food and Drug Administration (FDA) has asked Regeneron Pharmaceuticals Inc and Sanofi SA to assess the neurocognitive side effects of their experimental medicine. FDA says, "The agency is aware of concerns raised with neurocognitive adverse events and other lipid-lowering therapies, including statins, and as part of our … [Read more...]
You are here: Home / Archives for cholesterol drug